Article

The relationship between performance and fMRI signal during working memory in patients with schizophrenia, unaffected co-twins, and control subjects.

Department of Psychology, UCLA, Los Angeles, CA 90095-1563, USA.
Schizophrenia Research (Impact Factor: 4.43). 02/2007; 89(1-3):191-7. DOI: 10.1016/j.schres.2006.08.016
Source: PubMed

ABSTRACT While behavioral research shows working memory impairments in schizophrenics and their relatives, functional neuroimaging studies of patients and healthy controls show conflicting findings of hypo- and hyperactivation, possibly indicating different relationships between physiological activity and performance. In a between-subjects regression analysis of fMRI activation and performance, low performance was associated with relatively lower activation in patients than controls, while higher performance was associated with higher activation in patients than controls in DLPFC and parietal cortex, but not occipital cortex, with unaffected twins of schizophrenics being intermediate between the groups. Accordingly, this supports the idea that both hyper and hypoactivation may be possible along a continuum of behavioral performance in a way consistent with a neural inefficiency model. Further, this study offers preliminary evidence that the relationship between behavior and physiology in schizophrenia may be heritable.

0 Bookmarks
 · 
85 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Impaired cognitive function, along with positive and negative symptoms, is a core clinical feature of schizophrenia. Earlier studies suggest that impaired cognitive functioning should be assessed from the perspective of brain networks. The recently developed brainnetome approach to evaluating brain networks-an approach that was initially developed by Chinese scientists-provides a new methodology for studying this issue. In this paper we first introduce the concept of brainnetome. We then review recent progress in developing a brainnetome of impaired cognitive function in people with schizophrenia. The models of the relevant brain networks considered were created using data obtained from functional and anatomical brain imaging technologies at different levels of analysis: networks centered on regions of interest, networks related to specific cognitive functions, whole brain networks, and the attributes of brain networks. Finally, we discuss the current challenges and potential new directions for research about brainnetome.
    Shanghai archives of psychiatry. 02/2012; 24(1):3-10.
  • [Show abstract] [Hide abstract]
    ABSTRACT: Schizophrenia is a complex chronic mental illness that is characterized by positive, negative and cognitive symptoms. Cognitive deficits are most predictive of long-term outcomes, with abnormalities in memory being the most robust finding. The advent of functional magnetic resonance imaging (fMRI) has allowed exploring neural correlates of memory deficits in vivo. In this article, we will give a selective review of fMRI studies probing brain regions and functional networks that are thought to be related to abnormal memory performance in two memory systems prominently affected in schizophrenia; working memory and episodic memory. We revisit the classic "hypofrontality" hypothesis of working memory deficits and explore evidence for frontotemporal dysconnectivity underlying episodic memory abnormalities. We conclude that fMRI studies of memory deficits in schizophrenia are far from universal. However, the current literature does suggest that alterations are not isolated to a few brain regions, but are characterized by abnormalities within large-scale brain networks.
    Behavioral sciences (Basel, Switzerland). 09/2013; 3(3):330-47.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: There is a high prevalence of cannabis use reported in non-affective psychosis. Early prospective longitudinal studies conclude that cannabis use is a risk factor for psychosis, and neurochemical studies on cannabis have suggested potential mechanisms for this effect. Recent advances in the field of neuroscience and genetics may have important implications for our understanding of this relationship. Importantly, we need to better understand the vulnerability × cannabis interaction to shed light on the mediators of cannabis as a risk factor for psychosis. Thus, the present study reviews recent literature on several variables relevant for understanding the relationship between cannabis and psychosis, including age of onset, cognition, brain functioning, family history, genetics, and neurological soft signs (NSS) in non-affective psychosis. Compared with non-using non-affective psychosis, the present review shows that there seem to be fewer stable cognitive deficits in patients with cannabis use and psychosis, in addition to fewer NSS and possibly more normalized brain functioning, indicating less neurobiological vulnerability for psychosis. There are, however, some familiar and genetic vulnerabilities present in the cannabis psychosis group, which may influence the cannabis pathway to psychosis by increasing sensitivity to cannabis. Furthermore, an earlier age of onset suggests a different pathway to psychosis in the cannabis-using patients. Two alternative vulnerability models are presented to integrate these seemingly paradoxical findings.
    Frontiers in Psychiatry 01/2014; 5:159.

Full-text (2 Sources)

Download
20 Downloads
Available from
May 26, 2014